Bionano Genomics Inc (BNGO)
0.8896
+0.02
(+2.84%)
USD |
NASDAQ |
Apr 30, 16:00
0.8896
0.00 (0.00%)
After-Hours: 17:27
Bionano Genomics Net Income (Quarterly): -43.89M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -43.89M |
September 30, 2023 | -112.57M |
June 30, 2023 | -38.91M |
March 31, 2023 | -37.12M |
December 31, 2022 | -38.68M |
September 30, 2022 | -31.81M |
June 30, 2022 | -32.16M |
March 31, 2022 | -29.95M |
December 31, 2021 | -22.95M |
September 30, 2021 | -20.75M |
June 30, 2021 | -18.79M |
March 31, 2021 | -9.947M |
December 31, 2020 | -11.73M |
September 30, 2020 | -10.79M |
Date | Value |
---|---|
June 30, 2020 | -8.074M |
March 31, 2020 | -10.51M |
December 31, 2019 | -7.901M |
September 30, 2019 | -6.398M |
June 30, 2019 | -7.665M |
March 31, 2019 | -7.852M |
December 31, 2018 | -6.412M |
September 30, 2018 | -4.926M |
June 30, 2018 | -3.312M |
March 31, 2018 | -3.847M |
December 31, 2017 | -5.920M |
September 30, 2017 | -5.086M |
June 30, 2017 | -6.674M |
March 31, 2017 | -5.686M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-112.57M
Minimum
Sep 2023
-6.398M
Maximum
Sep 2019
-26.35M
Average
-20.75M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
Bruker Corp | 205.50M |
Azenta Inc | -15.72M |
Harvard Bioscience Inc | -1.818M |
Akoya Biosciences Inc | -10.80M |
Singular Genomics Systems Inc | -23.25M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 10.72M |
Total Expenses (Quarterly) | 35.67M |
EPS Diluted (Quarterly) | -0.96 |
Enterprise Value | 20.88M |
Gross Profit Margin (Quarterly) | 22.74% |
Profit Margin (Quarterly) | -409.4% |
Earnings Yield | -2.00K% |
Normalized Earnings Yield | -1802.58 |